Publications

Showing

0

out of

0

results

Detecting At-Risk Alzheimer's Disease Cases.

Fladby T, Palhaugen L, Selnes P,

December 31, 2016

Screening for Alzheimer's Disease: Cognitive Impairment in Self-Referred and Memory Clinic-Referred Patients.

Kirsebom BE, Espenes R, Waterloo K,

December 31, 2016

Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline.

Eliassen CF, Reinvang I, Selnes P,

December 31, 2016

White matter hyperintensity microstructure in amyloid dysmetabolism.

Kalheim LF, Bjornerud A, Fladby T,

December 31, 2016

Impaired synaptic function is linked to cognition in Parkinson's disease.

Selnes P, Stav AL, Johansen KK,

December 31, 2016

Cerebrospinal Fluid Levels of Amyloid Beta 1-43 Mirror 1-42 in Relation to Imaging Biomarkers of Alzheimer's Disease.

Almdahl IS, Lauridsen C, Selnes P,

December 31, 2016

Convergent Results from Neuropsychology and from Neuroimaging in Patients with Mild Cognitive Impairment.

Eliassen CF, Reinvang I, Selnes P,

December 31, 2016

Longitudinal evaluation of criteria for subjective cognitive decline and preclinical Alzheimer's disease in a memory clinic sample.

Eckerstrom M, Gothlin M, Rolstad S,

December 31, 2016

Psychometric properties of a Norwegian adaption of the Barratt Impulsiveness Scale-11 in a sample of Parkinson patients, headache patients, and controls.

Lindstrøm JC, Wyller NG, Halvorsen MM,

November 22, 2016

Amyloid Dysmetabolism Relates to Reduced Glucose Uptake in White Matter Hyperintensities.

Kalheim LF, Selnes P, Bjørnerud A,

November 20, 2016